Medicaments having psychotropic properties
AssigneePierre Fabre S.A.
InventorsM. Antoine Stenger, Henri Cousse, M. Gilbert Mouzin
Life of this patent
Estimating the term…
Abstract
The invention relates to new chemical compounds which can be used as drugs, as well as pharmaceutical compositions. The new products have the general formula: ##STR1## Drugs containing these active principles can be administered orally, rectally, parenterally or locally and are intended in particular for use as psychotropics, either alone or associated with other active principles. 5-Bromo-ortho-cresotamide may also be named 5-Bromo-2-hydroxy-3-methyl-benzamide.
Claims8
A composition useful for muscle relaxant, anti-convulsant and musculolytic purposes, which comprises an effective amount of a compound selected from the group consisting of a 5-bromo-N-(N',N'-dialkylaminoalkyl)-ortho-cresotamide wherein each of the alkyl moieties in the N',N'-dialkylamino moiety is methyl or ethyl, and the aminoalkyl is aminoethyl or aminopropyl, and a therapeutically acceptable salt thereof, together with a pharmaceutically-acceptable carrier or excipient.
A method of reducing the occurrence of muscle spasms and for relaxing muscles in a host which comprises administering to the host an effective amount of a compound selected from the group consisting of a 5-bromo-N-(N',N'-dialkylaminoalkyl)-ortho-cresotamide wherein each of the alkyl moieties in the N',N'-dialkylamino moiety is methyl or ethyl, and the aminoalkyl is aminoethyl or aminopropyl, and a therapeutically acceptable salt thereof.
A compound selected from the group consisting of a 5-bromo-N-(N', N'-dialkylaminoalkyl)-ortho-cresotamide wherein each of the alkyl moieties in the N',N'-dialkylamino moiety is methyl or ethyl, and the aminoalkyl is aminoethyl or aminopropyl, and a therapeutically acceptable salt thereof.
Dependencies are inferred from the claim text.